<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01225198</url>
  </required_header>
  <id_info>
    <org_study_id>AutismVitaminStudy2008</org_study_id>
    <nct_id>NCT01225198</nct_id>
  </id_info>
  <brief_title>Vitamin/Mineral Supplement for Children and Adults With Autism</brief_title>
  <official_title>New Vitamin/Mineral Supplement for Children and Adults With Autism - National Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arizona State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Autism Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Legacy Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Arizona State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesis is that a new, revised formulation of a vitamin/mineral
      supplement will result in:

        1. improvement of nutritional status in some children/adults with autism, and

        2. reduction of some of the symptoms of autism in some children
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The major goal of this study is to determine the effect of this vitamin/mineral supplement on
      levels of vitamins, minerals, neurotransmitters, and biomarkers for nutritional deficiencies.
      The study design is a randomized, double-blind, placebo-controlled. Blood and urine
      measurements will be measured at the beginning of the study in children with autism and
      typical children. Then, the children with autism will be given the supplement or placebo for
      12 weeks, and then their blood and urine will be re-measured.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxidative Stress</measure>
    <time_frame>Beginning of study (day 0)</time_frame>
    <description>Level of Plasma Nitrotyrosine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxidative Stress</measure>
    <time_frame>End of Study (after 12 weeks of treatment)</time_frame>
    <description>Level of plasma nitrotyrosine</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parent Global Impressions - Revised</measure>
    <time_frame>End of study (12 weeks)</time_frame>
    <description>The Average Change of the Parent Global Impressions (PGI-R) assessment tool.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">143</enrollment>
  <condition>Autism</condition>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Liquid placebo with identical packaging and flavoring to the real supplement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin/Mineral Supplement Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multi-vitamin/mineral supplement designed for this study for children and adults with autism spectrum disorders.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multi-Vitamin/Mineral Supplement</intervention_name>
    <description>A broad-spectrum vitamin/mineral supplement designed for children and adults with autism</description>
    <arm_group_label>Vitamin/Mineral Supplement Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Liquid Placebo</intervention_name>
    <description>The placebo was formulated to look and taste like the intervention supplement. A small amount of beta-carotene was used for coloring. Natural cherry, citric acid, and a proprietary blend of natural flavors were used for flavoring to create a vitamin-like after-taste. Sucralose was used as a sweetener and the same preservatives were included (potassium sorbate, sodium benzoate).</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age 3-60 years old;

          2. Autism Group: diagnosis of autism, pervasive developmental disorder/not otherwise
             specified (PDD/NOS), or Asperger's by a psychiatrist or similar professional

          3. Control Group: in good mental and physical health, and no siblings with autism
             spectrum disorders, and no evidence of Attention Deficit Disorder by parent report

        Exclusion Criteria:

          1. Usage of a vitamin/mineral supplement in the last 2 months

          2. Current use of any chelation treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James B. Adams, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arizona State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arizona State University</name>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <zip>85287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://autism.asu.edu</url>
    <description>Arizona State University Autism/Asperger's Research Program</description>
  </link>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2010</study_first_submitted>
  <study_first_submitted_qc>October 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2010</study_first_posted>
  <last_update_submitted>October 19, 2010</last_update_submitted>
  <last_update_submitted_qc>October 19, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>James B. Adams</name_title>
    <organization>Arizona State University</organization>
  </responsible_party>
  <keyword>Vitamins</keyword>
  <keyword>Minerals</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

